Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Total Non-Current Liabilities: 2014-2025

Historic Total Non-Current Liabilities for Nutex Health (NUTX) over the last 11 years, with Q1 2025 value amounting to $11.5 million.

  • Nutex Health's Total Non-Current Liabilities fell 955.62% to $11.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $47.6 million, marking a year-over-year decrease of 934.37%. This contributed to the annual value of $11.8 million for FY2024, which is 919.17% down from last year.
  • According to the latest figures from Q1 2025, Nutex Health's Total Non-Current Liabilities is $11.5 million, which was down 955.62% from $11.8 million recorded in Q4 2024.
  • Over the past 5 years, Nutex Health's Total Non-Current Liabilities peaked at $68.9 million during Q4 2021, and registered a low of $7.1 million during Q1 2022.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $12.8 million (2023), whereas its average is $17.1 million.
  • As far as peak fluctuations go, Nutex Health's Total Non-Current Liabilities tumbled by 7818.52% in 2022, and later skyrocketed by 9408.57% in 2023.
  • Quarter analysis of 5 years shows Nutex Health's Total Non-Current Liabilities stood at $68.9 million in 2021, then crashed by 78.19% to $15.0 million in 2022, then dropped by 13.72% to $13.0 million in 2023, then fell by 9.19% to $11.8 million in 2024, then decreased by 2.62% to $11.5 million in 2025.
  • Its last three reported values are $11.5 million in Q1 2025, $11.8 million for Q4 2024, and $12.1 million during Q3 2024.